Answers are grounded in this paper and cite their sources.
Summary The effects of a single intramuscular administration of polysulfated glycosaminoglycan (PSGAG, Adequan®a) on activated partial thromboplastin time (APTT), prothrombin time (PT), complete blood count (CBC), biochemical profile and urinalysis were determined in six adult cats. An injection of 5 mg/kg of PSGAG was given to three of the cats, and an injection of 25 mg/kg was given to the other three cats. Following a seven-day crossover interval, the doses were reversed. Serial blood and urine samples were collected over a 48-hour period after each injection. Administration of PSGAG resulted in a transient, dose-dependent increase of APTT and PT. Prolonged bleeding from the venipuncture sites in the 25 mg/kg group was observed. Some of the CBC, biochemical profile, and urinalysis values changed following treatment, but clinically significant adverse reactions were not noticed. Polysulfated glycosaminoglycan (Adequan®) is a heparin analogue with chondroprotective and anticoagulant properties. A single intramuscular injection of 5 mg/kg and 25 mg/kg of polysulfated glycosaminoglycan in six healthy adult cats resulted in a transient, dose-dependent increase of activated partial thromboplastin time and prothrombin time. Minor changes were seen on complete blood count, biochemical profile and urinalysis.
No takes yet. Share an insight, caveat, or question.
Beale et al. (1994) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: